UCB SA (UCB.BR)

EUR 146.5

(-0.58%)

Total Assets Summary of UCB SA

UCB SA's latest annual total assets in 2023 was 15.53 Billion EUR , down -2.07% from previous year.
UCB SA's latest quarterly total assets in 2024 Q2 was 15.62 Billion EUR , down 0.0% from previous quarter.
UCB SA reported annual total assets of 15.86 Billion EUR in 2022, up 11.67% from previous year.
UCB SA reported annual total assets of 14.21 Billion EUR in 2021, up 6.69% from previous year.
UCB SA reported quarterly total assets of 15.53 Billion EUR for 2023 FY, down -2.07% from previous quarter.
UCB SA reported quarterly total assets of 15.38 Billion EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of UCB SA (2023 - 2002)

Historical Annual Total Assets of UCB SA (2023 - 2002)

Year	Total Assets	Total Assets Growth
2023	15.53 Billion EUR	-2.07%
2022	15.86 Billion EUR	11.67%
2021	14.21 Billion EUR	6.69%
2020	13.31 Billion EUR	20.2%
2019	11.08 Billion EUR	5.39%
2018	10.51 Billion EUR	6.02%
2017	9.91 Billion EUR	-2.89%
2016	10.21 Billion EUR	-6.79%
2015	10.95 Billion EUR	7.96%
2014	10.14 Billion EUR	3.98%
2013	9.76 Billion EUR	4.27%
2012	9.36 Billion EUR	1.98%
2011	9.17 Billion EUR	2.33%
2010	8.96 Billion EUR	-1.66%
2009	9.12 Billion EUR	-4.24%
2008	9.52 Billion EUR	-0.32%
2007	9.55 Billion EUR	-8.98%
2006	10.49 Billion EUR	122.56%
2005	4.71 Billion EUR	-12.22%
2004	5.37 Billion EUR	73.85%
2003	3.09 Billion EUR	17.93%
2002	2.62 Billion EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	15.62 Billion EUR	0.0%
2023 FY	15.53 Billion EUR	-2.07%
2023 Q2	15.38 Billion EUR	0.0%
2023 Q4	15.53 Billion EUR	0.0%
2022 FY	15.86 Billion EUR	11.67%
2022 Q2	16.3 Billion EUR	0.0%
2022 Q4	15.86 Billion EUR	0.0%
2021 Q2	13.03 Billion EUR	0.0%
2021 Q4	14.21 Billion EUR	0.0%
2021 FY	14.21 Billion EUR	6.69%
2020 Q4	13.31 Billion EUR	0.0%
2020 Q2	13.21 Billion EUR	0.0%
2020 FY	13.31 Billion EUR	20.2%
2019 Q4	11.08 Billion EUR	0.0%
2019 FY	11.08 Billion EUR	5.39%
2019 Q2	10.51 Billion EUR	0.0%
2018 Q4	10.51 Billion EUR	0.0%
2018 FY	10.51 Billion EUR	6.02%
2018 Q2	10.19 Billion EUR	0.0%
2017 FY	9.91 Billion EUR	-2.89%
2017 Q2	9.8 Billion EUR	0.0%
2017 Q4	9.91 Billion EUR	0.0%
2016 Q4	10.21 Billion EUR	0.0%
2016 FY	10.21 Billion EUR	-6.79%
2016 Q2	10.19 Billion EUR	0.0%
2015 Q4	10.95 Billion EUR	0.0%
2015 Q2	10.55 Billion EUR	0.0%
2015 FY	10.95 Billion EUR	7.96%
2014 Q2	9.72 Billion EUR	0.0%
2014 FY	10.14 Billion EUR	3.98%
2014 Q4	10.14 Billion EUR	0.0%
2013 Q4	9.9 Billion EUR	0.0%
2013 FY	9.76 Billion EUR	4.27%
2013 Q2	9.55 Billion EUR	0.0%
2012 Q2	9.37 Billion EUR	0.0%
2012 FY	9.36 Billion EUR	1.98%
2012 Q4	9.36 Billion EUR	0.0%
2011 Q4	9.17 Billion EUR	0.0%
2011 Q2	8.5 Billion EUR	0.0%
2011 FY	9.17 Billion EUR	2.33%
2010 FY	8.96 Billion EUR	-1.66%
2010 Q4	8.96 Billion EUR	0.0%
2010 Q2	9.96 Billion EUR	0.0%
2009 Q4	9.12 Billion EUR	0.0%
2009 FY	9.12 Billion EUR	-4.24%
2008 FY	9.52 Billion EUR	-0.32%
2007 FY	9.55 Billion EUR	-8.98%
2006 FY	10.49 Billion EUR	122.56%
2005 FY	4.71 Billion EUR	-12.22%
2004 FY	5.37 Billion EUR	73.85%
2003 FY	3.09 Billion EUR	17.93%
2002 FY	2.62 Billion EUR	0.0%

Peer Total Assets Comparison of UCB SA

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	-29229.936%
European Medical Solutions	43.75 Million EUR	-35411.221%
FERMENTALG	50.24 Million EUR	-30827.076%
argenx SE	4.11 Billion EUR	-277.883%
BioSenic S.A.	9.55 Million EUR	-162458.845%
Celyad Oncology SA	16.28 Million EUR	-95336.679%
Hyloris Pharmaceuticals SA	47.68 Million EUR	-32489.501%
Onward Medical N.V.	43.62 Million EUR	-35516.219%
Oxurion NV	6.55 Million EUR	-237136.641%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-30186.316%
Financière de Tubize SA	1.92 Billion EUR	-709.22%